Exploring the Mechanism of Isoliquiritigenin on Lung Cancer Based on Network Pharmacology and Molecular Docking
Indian Journal of Pharmaceutical Education and Research · 23.04.2026 · 60 (3) · 1268-1275
DOI: 10.5530/ijper.20260503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Education and Research, online erschienen am 23.04.2026. Verfasst von Guibin Weng und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Weng, G., Fang, W., Su, W., Chen, L., Liao, M., & Lin, Y. (2026). Exploring the Mechanism of Isoliquiritigenin on Lung Cancer Based on Network Pharmacology and Molecular Docking. Indian Journal of Pharmaceutical Education and Research, 60(3), 1268-1275. https://doi.org/10.5530/ijper.20260503
Vancouver
Weng G, Fang W, Su W, Chen L, Liao M, Lin Y. Exploring the Mechanism of Isoliquiritigenin on Lung Cancer Based on Network Pharmacology and Molecular Docking. Indian Journal of Pharmaceutical Education and Research. 2026;60(3):1268-1275. doi:10.5530/ijper.20260503
BibTeX
@article{Weng2026,
author = {Weng, Guibin and Fang, Weimin and Su, Weikun and Chen, Lin and Liao, Menglin and Lin, Yijin},
title = {Exploring the Mechanism of Isoliquiritigenin on Lung Cancer Based on Network Pharmacology and Molecular Docking},
journal = {Indian Journal of Pharmaceutical Education and Research},
year = {2026},
volume = {60},
number = {3},
pages = {1268--1275},
doi = {10.5530/ijper.20260503}
}
EUVIMED